What drove TMCI's consistent EPS growth in 2024?
4/12/2025 06:14pm
Treace Medical (TMCI) experienced a decline in earnings per share (EPS) rather than growth in 2024, with a decrease of $0.59 from the first quarter to the third quarter. Therefore, it is not accurate to claim that there was a consistent EPS growth in 2024. The factors contributing to this decline are as follows: